Citations: Young,Shih-Houng; Antonini,James M.; Roberts,Jenny R.; Erdely,Aaron D.; Zeidler-Erdely,Patti C.. Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models. Journal of Immunological Methods 2008;331:59-68. (Link)
References: Carr,M.W.; Roth,S.J.; Luther,E.; Rose,S.S.; Springer,T.A.. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc.Natl.Acad.Sci.U.S.A 1994;91:3652-3656. (Link)
Kuna,P.; Reddigari,S.R.; Rucinski,D.; Oppenheim,J.J.; Kaplan,A.P.. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J.Exp.Med. 1992;175:489-493. (Link)
Shyy,Y.J.; Li,Y.S.; Kolattukudy,P.E.. Structure of human monocyte chemotactic protein gene and its regulation by TPA. Biochem.Biophys.Res.Commun. 1990;169:346-351. (Link)
Yoshimura,T.; Yuhki,N.; Moore,S.K.; Appella,E.; Lerman,M.I.; Leonard,E.J.. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 1989;244:487-493. (Link)
Namiki,M.; Kawashima,S.; Yamashita,T.; Ozaki,M.; Hirase,T.; Ishida,T.; Inoue,N.; Hirata,K.; Matsukawa,A.; Morishita,R.; Kaneda,Y.; Yokoyama,M.. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler.Thromb.Vasc.Biol. 2002;22:115-120. (Link)
Edwards,J.A.; Denis,F.; Talbot,P.J.. Activation of glial cells by human coronavirus OC43 infection 34. J.Neuroimmunol. 2000;108:73-81. (Link)
Tarzami,S.T.; Cheng,R.; Miao,W.; Kitsis,R.N.; Berman,J.W.. Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death 119. J.Mol.Cell Cardiol. 2002;34:209-221. (Link)
Mahad,D.J.; Howell,S.J.; Woodroofe,M.N.. Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis. J.Neurol.Neurosurg.Psychiatry 2002;72:498-502. (Link)
McManus,C.; Berman,J.W.; Brett,F.M.; Staunton,H.; Farrell,M.; Brosnan,C.F.. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J.Neuroimmunol. 1998;86:20-29. (Link)
Grammas,P.; Ovase,R.. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol.Aging 2001;22:837-842. (Link)
Mateo,L.; La,Linn M.; McColl,S.R.; Cross,S.; Gardner,J.; Suhrbier,A.. An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8 86. Intervirology 2000;43:55-60. (Link)
Graves,D.T.; Jiang,Y.; Valente,A.J.. The expression of monocyte chemoattractant protein-1 and other chemokines by osteoblasts. Front Biosci. 1999;4:D571-D580. (Link)
Baggiolini,M.; Dewald,B.; Moser,B.. Human chemokines: an update. Annu.Rev.Immunol. 1997;15:675-705. (Link)
Proost,P.; Wuyts,A.; Van,Damme J.. The role of chemokines in inflammation. Int.J.Clin.Lab Res. 1996;26:211-223. (Link)
Taub,D.D.; Proost,P.; Murphy,W.J.; Anver,M.; Longo,D.L.; Van,Damme J.; Oppenheim,J.J.. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J.Clin.Invest 1995;95:1370-1376. (Link)